ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer.
Gong Y, Hu N, Ma L, Li W, Cheng X, Zhang Y, Zhu Y, Yang Y, Peng X, Zou D, Tian J, Yang L, Mei S, Wang X, Lo CH, Chang J, Hou T, Zhang H, Xu B, Zhong R, Yuan P.
Gong Y, et al. Among authors: zhang h, zhang y.
Front Oncol. 2020 Sep 25;10:571517. doi: 10.3389/fonc.2020.571517. eCollection 2020.
Front Oncol. 2020.
PMID: 33102228
Free PMC article.